Pharmacyte Biotech logo

Pharmacyte Biotech share price today

(PMCB)

Pharmacyte Biotech share price is $1.64 & ₹139.36 as on 21 Dec 2024, 2.30 'hrs' IST

$1.64

Market is closed - opens 8 PM, 23 Dec 2024

View live Pharmacyte Biotech share price in Dollar and Rupees. Guide to invest in Pharmacyte Biotech from India. Also see the sentimental analysis on Indian investors investing in Pharmacyte Biotech. Get details on the Indian mutual funds that are investing in Pharmacyte Biotech. Get Analyst recommendations and forecasts along with all the Pharmacyte Biotech's financials.

Pharmacyte Biotech share price movements

  • Today's Low: $1.60
    Today's High: $1.64

    Day's Volatility :2.73%

  • 52 Weeks Low: $1.39
    52 Weeks High: $2.58

    52 Weeks Volatility :46.12%

Pharmacyte Biotech Returns

PeriodPharmacyte Biotech IncIndex (Russel 2000)
3 Months
-7.87%
0.0%
6 Months
-21.15%
0.0%
1 Year
-26.79%
0.0%
3 Years
-36.68%
-19.7%

Pharmacyte Biotech Key Statistics

in dollars & INR

Previous Close
$1.64
Open
$1.64
Today's High
$1.6449
Today's Low
$1.6
Market Capitalization
$11.4M
Today's Volume
$13.8K
52 Week High
$2.58
52 Week Low
$1.39
Revenue TTM
$0.0
Earnings Per Share (EPS)
$0.88
PE Ratio
1.86
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
47.88%

How to invest in Pharmacyte Biotech from India?

It is very easy for Indian residents to invest directly in Pharmacyte Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pharmacyte Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pharmacyte Biotech or PMCB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pharmacyte Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pharmacyte Biotech shares which would translate to 0.518 fractional shares of Pharmacyte Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Pharmacyte Biotech, in just a few clicks!

Returns in Pharmacyte Biotech for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pharmacyte Biotech investment value today

Current value as on today

₹1,28,982

Returns

₹28,982

(+28.98%)

Returns from Pharmacyte Biotech Stock

₹26,786 (false-26.79%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Pharmacyte Biotech

30%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Pharmacyte Biotech on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 30% more investors are searching Pharmacyte Biotech in the last 30 days versus the previous period.

Global Institutional Holdings in Pharmacyte Biotech

  • K2 PRINCIPAL FUND LP

    2.73%

  • Vanguard Group Inc

    2.51%

  • Geode Capital Management, LLC

    2.19%

  • EQUITEC PROPRIETARY MARKETS, LLC

    1.08%

  • Renaissance Technologies Corp

    0.65%

  • Susquehanna International Group, LLP

    0.46%

Analyst Recommendation on Pharmacyte Biotech

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Pharmacyte Biotech(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Insights on Pharmacyte Biotech

  • Price Movement

    In the last 6 months, PMCB stock has moved down by -15.9%
  • PMCB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 61.0%
  • PMCB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 60.4%

Pharmacyte Biotech Technicals Summary

Sell

Neutral

Buy

Pharmacyte Biotech is currently in a neutral trading position according to technical analysis indicators.

Pharmacyte Biotech Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pharmacyte Biotech Inc
-6.29%
-21.15%
-26.79%
-36.68%
-45.87%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pharmacyte Biotech Inc
1.86
1.86
0.0
0.0
0.48
-0.05
NA
3.44
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pharmacyte Biotech Inc
Sell
$11.4M
-45.87%
1.86
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Pharmacyte Biotech

pharmacyte biotech, inc., a clinical stage biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the united states. its cellular therapies are developed based on cell-in-a-box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. the company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. it is also developing a therapy for type 1 diabetes and insulin-dependent type 2 diabetes; and therapies for cancer based on the constituents of the cannabis plant. pharmacyte biotech, inc. has a research agreement with the university of technology, sydney to create a version of melligen cells to treat diabetes; and a research agreeme
Organization
Pharmacyte Biotech
Employees
2
CEO
Mr. Joshua N. Silverman
Industry
Consumer Sundries

Management People of Pharmacyte Biotech

NameTitle
Mr. Joshua N. Silverman
Interim CEO, Interim President & Interim Chairman
Mr. Carlos A. Trujillo CPA, CPA
Chief Financial Officer
Dr. Jose L. Iglesias M.D.
Consulting Chief Medical Officer
Dr. Hans-Peter Hammes
Member of Medical & Scientific Advisory Board and Consultant

Important FAQs about investing in Pharmacyte Biotech from India :

What is Pharmacyte Biotech share price today?

Pharmacyte Biotech share price today stands at $1.64, Open: $1.64 ; Previous Close: $1.64 ; High: $1.64 ; Low: $1.60 ; 52 Week High: $2.58 ; 52 Week Low: $1.39. The stock opens at $1.64, after a previous close of $1.64. The stock reached a daily high of $1.64 and a low of $1.60, with a 52-week high of $2.58 and a 52-week low of $1.39.

Can Indians buy Pharmacyte Biotech shares?

Yes, Indians can invest in the Pharmacyte Biotech (PMCB) from India.

With INDmoney, you can buy Pharmacyte Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pharmacyte Biotech at zero transaction cost.

How can I buy Pharmacyte Biotech shares from India?

It is very easy to buy Pharmacyte Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pharmacyte Biotech be purchased?

Yes, you can buy fractional shares of Pharmacyte Biotech with INDmoney app.

What are the documents required to start investing in Pharmacyte Biotech stocks?

To start investing in Pharmacyte Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pharmacyte Biotech

Today’s highest price of Pharmacyte Biotech (PMCB) is $1.64.

Today’s lowest price of Pharmacyte Biotech (PMCB) is $1.60.

What is today's market capitalisation of Pharmacyte Biotech

Today's market capitalisation of Pharmacyte Biotech PMCB is 11.4M

What is the 52 Week High and Low Range of Pharmacyte Biotech

  • 52 Week High

    $2.58

  • 52 Week Low

    $1.39

What are the historical returns of Pharmacyte Biotech?

  • 1 Month Returns

    -6.29%

  • 3 Months Returns

    -21.15%

  • 1 Year Returns

    -26.79%

  • 5 Years Returns

    -45.87%

Who is the Chief Executive Officer (CEO) of Pharmacyte Biotech

Mr. Joshua N. Silverman is the current Chief Executive Officer (CEO) of Pharmacyte Biotech.